Export And Import Of Other Pharmaceuticals Companies in Malaysia

The pharmaceutical industry in Malaysia is well-developed and growing rapidly. The country's political stability, strong economy, and pro-business environment make it an attractive destination for foreign pharmaceutical companies. The Malaysian government is committed to improving the country's healthcare system and has been investing heavily in the sector in recent years.

The Malaysian market for pharmaceuticals is estimated to be worth around US$3.5 billion. The government is the largest buyer of pharmaceuticals, accounting for around 60% of total sales. The private sector is the second largest buyer, accounting for around 30% of total sales. The remaining 10% of sales are made to other buyers such as hospitals and clinics.

The majority of pharmaceuticals consumed in Malaysia are imported. In 2017, Malaysia imported pharmaceuticals worth US$2.6 billion. The United States is the largest supplier of pharmaceuticals to Malaysia, accounting for around 30% of total imports. Other major suppliers include India, China, and Singapore.

The Malaysian government has been encouraging the development of the local pharmaceutical industry in recent years. A number of incentives are available to companies that manufacture pharmaceuticals in Malaysia, including tax exemptions and duty-free imports of raw materials. As a result of these incentives, a number of foreign